The Community Guide

- gsearch

Search Results

Narrow Results:

2022 1
2021 9
2020 4
2019 2
2018 1
2013 2

United States 4

Charts, Diagrams, Etc. 2
Fact Sheet 1

1 - 19 of 19 Results

Refine Results

Refine Results:

Contact Tracing workflow in a non-US setting

CITE Title : Contact Tracing workflow in a non-US setting Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 21, 2020 Series : Coronavirus Disease 2020 (COVID-19);Get and keep America open; URL : https://stacks.cdc.gov/view/cdc/95765 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Contact Tracing workflow in a non-US setting. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Contact Tracing workflow in a non-US setting" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Contact Tracing workflow in a non-US setting" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 21, 2020 | Coronavirus Disease 2020 (COVID-19)

:

Updated Oct. 21, 2020This document is intended to be professionally generated as a job aid for distribution via CDC country offices to local Ministrie...
Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program

CITE Title : Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program Personal Author(s) : Hey, Spencer Phillips;Heilig, Charles M;Weijer, Charles; Published Date : May 30 2013 Source : Trials. 2013; 14:159. URL : https://stacks.cdc.gov/view/cdc/13669 Hey, Spencer Phillips et al. (2013). Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program. 14 Hey, Spencer Phillips and Heilig, Charles M and Weijer, Charles "Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program" 14 (2013) Hey, Spencer Phillips et al. "Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program" vol. 14, 2013 Export RIS Citation Information.

:

Hey, Spencer Phillips ;

Heilig, Charles M

May 30 2013 | Trials. 2013; 14:159.

:

BackgroundMaximizing efficiency in drug development is important for drug developers, policymakers, and human subjects. Limited funds and the ethical ...
Case investigation workflow (COVID-19)

CITE Title : Case investigation workflow (COVID-19) Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 06/15/2020 URL : https://stacks.cdc.gov/view/cdc/89423 Centers for Disease Control and Prevention (U.S.) (2020). Case investigation workflow (COVID-19). Centers for Disease Control and Prevention (U.S.) "Case investigation workflow (COVID-19)" (2020) Centers for Disease Control and Prevention (U.S.) "Case investigation workflow (COVID-19)" , 2020 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

06/15/2020

:

Accessible version https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/investigating-coivd-19-case.htmlcdc.gov/COVID19C...
What you can do if you are at increased risk of severe illness from COVID-19 [Tigrinya]

CITE Title : What you can do if you are at increased risk of severe illness from COVID-19 [Tigrinya] Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : June 16, 2021 URL : https://stacks.cdc.gov/view/cdc/107869 Centers for Disease Control and Prevention (U.S.) (2021). What you can do if you are at increased risk of severe illness from COVID-19 [Tigrinya]. Centers for Disease Control and Prevention (U.S.) "What you can do if you are at increased risk of severe illness from COVID-19 [Tigrinya]" (2021) Centers for Disease Control and Prevention (U.S.) "What you can do if you are at increased risk of severe illness from COVID-19 [Tigrinya]" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

June 16, 2021

:

What you can do if you are at increased risk of severe illness from COVID-19 [Tigrinya]cdc.gov/coronavirus324017-QJune 16, 2021 4:55 PMRefugees-what-y...
O que pode fazer se correr um risco mais elevado de doença grave da COVID-19

CITE Title : O que pode fazer se correr um risco mais elevado de doença grave da COVID-19 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : June 15, 2021 URL : https://stacks.cdc.gov/view/cdc/107864 Centers for Disease Control and Prevention (U.S.) (2021). O que pode fazer se correr um risco mais elevado de doença grave da COVID-19. Centers for Disease Control and Prevention (U.S.) "O que pode fazer se correr um risco mais elevado de doença grave da COVID-19" (2021) Centers for Disease Control and Prevention (U.S.) "O que pode fazer se correr um risco mais elevado de doença grave da COVID-19" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

June 15, 2021

:

What you can do if you are at increased risk of severe illness from COVID-19 [Portuguese]Ligue ao seu prestador de cuidados de saúde se estiver doen...
Lo que puede hacer si está en mayor riesgo de enfermarse gravemente por el COVID-19

CITE Title : Lo que puede hacer si está en mayor riesgo de enfermarse gravemente por el COVID-19 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : junio 17, 2021 URL : https://stacks.cdc.gov/view/cdc/107867 Centers for Disease Control and Prevention (U.S.) (2021). Lo que puede hacer si está en mayor riesgo de enfermarse gravemente por el COVID-19. Centers for Disease Control and Prevention (U.S.) "Lo que puede hacer si está en mayor riesgo de enfermarse gravemente por el COVID-19" (2021) Centers for Disease Control and Prevention (U.S.) "Lo que puede hacer si está en mayor riesgo de enfermarse gravemente por el COVID-19" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

junio 17, 2021

:

What you can do if you are at increased risk of severe illness from COVID-19 [Spanish]Llame a su profesional de atención médica si está enfermo....
Что вы можете сделать, если вы находитесь в группе повышенного риска развития тяжелой болезни, вызванной COVID-19

CITE Title : Что вы можете сделать, если вы находитесь в группе повышенного риска развития тяжелой болезни, вызванной COVID-19 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : June 10, 2021 URL : https://stacks.cdc.gov/view/cdc/107865 Centers for Disease Control and Prevention (U.S.) (2021). Что вы можете сделать, если вы находитесь в группе повышенного риска развития тяжелой болезни, вызванной COVID-19. Centers for Disease Control and Prevention (U.S.) "Что вы можете сделать, если вы находитесь в группе повышенного риска развития тяжелой болезни, вызванной COVID-19" (2021) Centers for Disease Control and Prevention (U.S.) "Что вы можете сделать, если вы находитесь в группе повышенного риска развития тяжелой болезни, вызванной COVID-19" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

June 10, 2021

:

What you can do if you are at increased risk of severe illness from COVID-19 [Russian]Позвоните вашему лечащему врачу, е�...
Що робити, якщо ви знаходитеся у групі підвищеного ризику тяжкої хвороби, спричиненої COVID-19

CITE Title : Що робити, якщо ви знаходитеся у групі підвищеного ризику тяжкої хвороби, спричиненої COVID-19 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : June 10, 2021 URL : https://stacks.cdc.gov/view/cdc/107870 Centers for Disease Control and Prevention (U.S.) (2021). Що робити, якщо ви знаходитеся у групі підвищеного ризику тяжкої хвороби, спричиненої COVID-19. Centers for Disease Control and Prevention (U.S.) "Що робити, якщо ви знаходитеся у групі підвищеного ризику тяжкої хвороби, спричиненої COVID-19" (2021) Centers for Disease Control and Prevention (U.S.) "Що робити, якщо ви знаходитеся у групі підвищеного ризику тяжкої хвороби, спричиненої COVID-19" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

June 10, 2021

:

What you can do if you are at increased risk of severe illness from COVID-19 [Ukrainian]Зателефонуйте своєму лікарю, якщ...
Waxa Aad Sameyn Karto haddii Aad Halis Sarreysa ugu Jirto Jirrada Daran ee COVID-19

CITE Title : Waxa Aad Sameyn Karto haddii Aad Halis Sarreysa ugu Jirto Jirrada Daran ee COVID-19 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : June 10, 2021 URL : https://stacks.cdc.gov/view/cdc/107866 Centers for Disease Control and Prevention (U.S.) (2021). Waxa Aad Sameyn Karto haddii Aad Halis Sarreysa ugu Jirto Jirrada Daran ee COVID-19. Centers for Disease Control and Prevention (U.S.) "Waxa Aad Sameyn Karto haddii Aad Halis Sarreysa ugu Jirto Jirrada Daran ee COVID-19" (2021) Centers for Disease Control and Prevention (U.S.) "Waxa Aad Sameyn Karto haddii Aad Halis Sarreysa ugu Jirto Jirrada Daran ee COVID-19" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

June 10, 2021

:

What you can do if you are at increased risk of severe illness from COVID-19 [Somali]Wac xirfadlaha daryeelkaaga caafimaad haddii aad jirran tahay.Wix...
Kile unaweza kufanya Ukiwa katika Hatari Kubwa ya kupatwa na Madhara Makali ya Ugonjwa wa COVID-19

CITE Title : Kile unaweza kufanya Ukiwa katika Hatari Kubwa ya kupatwa na Madhara Makali ya Ugonjwa wa COVID-19 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : June 17, 2021 URL : https://stacks.cdc.gov/view/cdc/107868 Centers for Disease Control and Prevention (U.S.) (2021). Kile unaweza kufanya Ukiwa katika Hatari Kubwa ya kupatwa na Madhara Makali ya Ugonjwa wa COVID-19. Centers for Disease Control and Prevention (U.S.) "Kile unaweza kufanya Ukiwa katika Hatari Kubwa ya kupatwa na Madhara Makali ya Ugonjwa wa COVID-19" (2021) Centers for Disease Control and Prevention (U.S.) "Kile unaweza kufanya Ukiwa katika Hatari Kubwa ya kupatwa na Madhara Makali ya Ugonjwa wa COVID-19" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

June 17, 2021

:

What you can do if you are at increased risk of severe illness from COVID-19 [Swahili]Mpigie simu mtaalamu wako wa huduma ya afya ikiwa umekuwa mgonjw...
Contact tracing workflow (COVID-19)

CITE Title : Contact tracing workflow (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : 06/15/2020 URL : https://stacks.cdc.gov/view/cdc/89422 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Contact tracing workflow (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Contact tracing workflow (COVID-19)" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Contact tracing workflow (COVID-19)" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

06/15/2020

:

Accessible version https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/contact-tracing.htmlcdc.gov/COVID19CS 317008-A 0...
Implementation of a Workflow Initiative for Integrating Transitional Care Management Codes in a Geriatric Primary Care Practice

CITE Title : Implementation of a Workflow Initiative for Integrating Transitional Care Management Codes in a Geriatric Primary Care Practice Personal Author(s) : Steckbeck, Julia;McBain, Christi;Terrien, Kerry L.;Isom, David;Stadler, Daniel;Stahl, James E.;Batsis, John A.; Published Date : 2018;Oct-Dec 2018; Source : J Nurs Care Qual. 33(4):348-353 URL : https://stacks.cdc.gov/view/cdc/56270 Steckbeck, Julia et al. (2018). Implementation of a Workflow Initiative for Integrating Transitional Care Management Codes in a Geriatric Primary Care Practice. 33(4). Steckbeck, Julia et al. "Implementation of a Workflow Initiative for Integrating Transitional Care Management Codes in a Geriatric Primary Care Practice" 33, no. 4 (2018) Steckbeck, Julia et al. "Implementation of a Workflow Initiative for Integrating Transitional Care Management Codes in a Geriatric Primary Care Practice" vol. 33, no. 4, 2018 Export RIS Citation Information.

:

Steckbeck, Julia ;

McBain, Christi

2018 | J Nurs Care Qual. 33(4):348-353

:

We implemented a transitional care management service led by a nurse care manager. An interdisciplinary team developed a workflow using a Plan-Do-Stud...
Use of Staged Molecular Analysis to Determine Causes of Unexplained Central Nervous System Infections

CITE Title : Use of Staged Molecular Analysis to Determine Causes of Unexplained Central Nervous System Infections Personal Author(s) : Hsu, Chien-Chin;Tokarz, Rafal;Briese, Thomas;Tsai, Hung-Chin;Quan, Phenix-Lan;Lipkin, W. Ian; Published Date : 2013 Source : Emerg Infect Dis. 19(9):1470-1477. URL : https://stacks.cdc.gov/view/cdc/20906 Hsu, Chien-Chin et al. (2013). Use of Staged Molecular Analysis to Determine Causes of Unexplained Central Nervous System Infections. 19(9). Hsu, Chien-Chin et al. "Use of Staged Molecular Analysis to Determine Causes of Unexplained Central Nervous System Infections" 19, no. 9 (2013) Hsu, Chien-Chin et al. "Use of Staged Molecular Analysis to Determine Causes of Unexplained Central Nervous System Infections" vol. 19, no. 9, 2013 Export RIS Citation Information.

:

Hsu, Chien-Chin ;

Tokarz, Rafal

2013 | Emerg Infect Dis. 19(9):1470-1477.

:

No agent is implicated in most central nervous system (CNS) infections. To investigate cerebrospinal fluid samples from patients with CNS infections o...
Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings

CITE Title : Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings Personal Author(s) : Beall, Shivani G.;Cantera, Jason;Diaz, Maureen H.;Winchell, Jonas M.;Lillis, Lorraine;White, Heather;Kalnoky, Michael;Gallarda, James;Boyle, David S.; Published Date : April 18 2019 Source : PLoS One. 14(4) URL : https://stacks.cdc.gov/view/cdc/85385 Beall, Shivani G. et al. (2019). Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings. 14(4). Beall, Shivani G. et al. "Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings" 14, no. 4 (2019) Beall, Shivani G. et al. "Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings" vol. 14, no. 4, 2019 Export RIS Citation Information.

:

Beall, Shivani G. ;

Cantera, Jason

April 18 2019 | PLoS One. 14(4)

:

Infectious disease nucleic acid amplification technologies (NAAT) have superior sensitivity, specificity, and rapid time to result compared to traditi...
Standardized workflows improve colonoscopy follow-up after abnormal fecal immunochemical tests in a safety-net system

CITE Title : Standardized workflows improve colonoscopy follow-up after abnormal fecal immunochemical tests in a safety-net system Personal Author(s) : Issaka, Rachel B.;Rachocki, Carly;Huynh, Michael P.;Chen, Ellen;Somsouk, Ma; Published Date : 3 2021 Source : Dig Dis Sci. 66(3):768-774 URL : https://stacks.cdc.gov/view/cdc/94618 Issaka, Rachel B. et al. (2021). Standardized workflows improve colonoscopy follow-up after abnormal fecal immunochemical tests in a safety-net system. 66(3). Issaka, Rachel B. et al. "Standardized workflows improve colonoscopy follow-up after abnormal fecal immunochemical tests in a safety-net system" 66, no. 3 (2021) Issaka, Rachel B. et al. "Standardized workflows improve colonoscopy follow-up after abnormal fecal immunochemical tests in a safety-net system" vol. 66, no. 3, 2021 Export RIS Citation Information.

:

Issaka, Rachel B. ;

Rachocki, Carly

3 2021 | Dig Dis Sci. 66(3):768-774

:

Background:How clinical teams function varies across sites and may affect follow-up of abnormal fecal immunochemical test (FIT) results.Aims:This stud...
A New Automated Method for the Analysis of Aromatic Amines in Human Urine by GC–MS/MS†

CITE Title : A New Automated Method for the Analysis of Aromatic Amines in Human Urine by GC–MS/MS† Personal Author(s) : Mazumder, Shrila;Ahamed, Rayaj A.;McGahee, Ernest;Wang, Lanqing;Seyler, Tiffany H.; Published Date : 1 01 2019;1-01-; Source : J Anal Toxicol. 43(1):25-35 URL : https://stacks.cdc.gov/view/cdc/61898 Mazumder, Shrila et al. (2019). A New Automated Method for the Analysis of Aromatic Amines in Human Urine by GC–MS/MS†. 43(1). Mazumder, Shrila et al. "A New Automated Method for the Analysis of Aromatic Amines in Human Urine by GC–MS/MS†" 43, no. 1 (2019) Mazumder, Shrila et al. "A New Automated Method for the Analysis of Aromatic Amines in Human Urine by GC–MS/MS†" vol. 43, no. 1, 2019 Export RIS Citation Information.

:

Mazumder, Shrila ;

Ahamed, Rayaj A.

1 01 2019 | J Anal Toxicol. 43(1):25-35

:

Cigarette smoking significantly increases the risk of cancer and cardiovascular diseases as well as premature death. Aromatic amines (AAs) such as o-t...
Facile Preparation of Peptides for Mass Spectrometry Analysis in Bottom-Up Proteomics Workflows

CITE Title : Facile Preparation of Peptides for Mass Spectrometry Analysis in Bottom-Up Proteomics Workflows Personal Author(s) : Wojtkiewicz, Melinda;Berg Luecke, Linda;Kelly, Maia I.;Gundry, Rebekah L.; Published Date : 3 2021;3-2021; Source : Curr Protoc. 1(3):e85 URL : https://stacks.cdc.gov/view/cdc/119170 Wojtkiewicz, Melinda et al. (2021). Facile Preparation of Peptides for Mass Spectrometry Analysis in Bottom-Up Proteomics Workflows. 1(3). Wojtkiewicz, Melinda et al. "Facile Preparation of Peptides for Mass Spectrometry Analysis in Bottom-Up Proteomics Workflows" 1, no. 3 (2021) Wojtkiewicz, Melinda et al. "Facile Preparation of Peptides for Mass Spectrometry Analysis in Bottom-Up Proteomics Workflows" vol. 1, no. 3, 2021 Export RIS Citation Information.

:

Wojtkiewicz, Melinda

;

Berg Luecke, Linda

3 2021 | Curr Protoc. 1(3):e85

:

Mass spectrometry (MS) is routinely used to identify, characterize, and quantify biological molecules. For protein analysis, MS-based workflows can be...
Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows

CITE Title : Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows Personal Author(s) : Lagerborg, Kim A.;Normandin, Erica;Bauer, Matthew R.;Adams, Gordon;Figueroa, Katherine;Loreth, Christine;Gladden-Young, Adrianne;Shaw, Bennett M.;Pearlman, Leah R.;Berenzy, Daniel;Dewey, Hannah B.;Kales, Susan;Dobbins, Sabrina T.;Shenoy, Erica S.;Hooper, David;Pierce, Virginia M.;Zachary, Kimon C.;Park, Daniel J.;MacInnis, Bronwyn L.;Tewhey, Ryan;Lemieux, Jacob E.;Sabeti, Pardis C.;Reilly, Steven K;Siddle, Katherine J.; Published Date : 1 2022;1-2022; Source : Nat Microbiol. 7(1):108-119 URL : https://stacks.cdc.gov/view/cdc/115460 Lagerborg, Kim A. et al. (2022). Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows. 7(1). Lagerborg, Kim A. et al. "Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows" 7, no. 1 (2022) Lagerborg, Kim A. et al. "Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows" vol. 7, no. 1, 2022 Export RIS Citation Information.

:

Lagerborg, Kim A. ;

Normandin, Erica

1 2022 | Nat Microbiol. 7(1):108-119

:

The global spread and continued evolution of SARS-CoV-2 has driven an unprecedented surge in viral genomic surveillance. Amplicon-based sequencing met...
COVID-19 Contact Tracing Workflow

CITE Title : COVID-19 Contact Tracing Workflow Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : 09/18/2020 Pages in Document : 4 unnumbered pages Series : Coronavirus Disease 2020 (COVID-19);Get and keep America open; URL : https://stacks.cdc.gov/view/cdc/93935 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). COVID-19 Contact Tracing Workflow. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 Contact Tracing Workflow" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 Contact Tracing Workflow" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

09/18/2020 | Coronavirus Disease 2020 (COVID-19)

:

COVID-19 Contact Tracing Workflow: Single Exposure -- COVID-19 Contact Tracing Workflow: Continuous Exposure -- Tracing Contacts of COVID-19 Cases -- ...